Exclusive-Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review

By Jennifer Rigby LONDON (Reuters) – New highly-effective weight loss drugs such as Novo Nordisk’s Wegovy are not a “silver bullet” for addressing the rapid rise in global obesity rates, the World Health Organization’s nutrition chief told Reuters, as the agency conducts its first review of obesity management guidelines in more than 20 years.    The…

Read More

GSK sells partial stake in spin-off firm Haleon at discount

(Reuters) -British drugmaker GSK on Friday said it sold 240 million shares in its consumer healthcare business Haleon at 335 pence per share, raising about 804 million pounds ($1.01 billion). Haleon, the world’s biggest standalone consumer health company, comprising assets from GSK and Pfizer, sells non-prescription drugs, vitamins and oral care products. The sale price…

Read More

Explainer-Title 42: what is the US border policy and what happens when it ends?

By Ted Hesson (Reuters) – The United States is set to lift COVID-19 restrictions on Thursday night, known as Title 42, which have been in place for three years and allow border agents to quickly expel many migrants caught crossing the border back to Mexico. Immigration processing will revert to a pre-existing system, known as…

Read More

Canada’s Sun Life beats profit estimates on strong insurance sales

(Reuters) -Canada’s second-biggest life insurer Sun Life Financial Inc on Thursday beat analysts’ estimates for first-quarter profit, powered by strong insurance sales at home and in the United States. Chief Executive Officer Kevin Strain said the insurer generated “strong growth in both health and protection sales,” as consumers prioritized health and financial security. Sun Life…

Read More

Teen mental health emergency visits decline in U.S. as pandemic eases, CDC says

(Reuters) – U.S. adolescents made fewer weekly emergency department (ED) visits for mental health conditions in Fall 2022 compared to a year earlier, researchers at the Centers for Disease Control and Prevention (CDC) reported on Thursday. By late 2022, pandemic restrictions had been loosened or lifted and adolescents had generally returned to schools, with better…

Read More

Insulin makers testify on Capitol Hill over prices

By Ahmed Aboulenein WASHINGTON (Reuters) – Leaders of major insulin makers and pharmacy benefit managers (PBMs) traded blame for the life-saving drug’s high price on Wednesday while testifying at a U.S. Senate committee hearing on making it more affordable. PBMs negotiate with drugmakers for rebates and lower fees on behalf of employers and other clients,…

Read More

Western motion to monitor Sudan abuses ekes past at UN rights body

By Emma Farge and Gabrielle Tétrault-Farber GENEVA (Reuters) -The U.N. Human Rights Council on Thursday narrowly passed a motion to increase monitoring of human rights abuses in Sudan where hundreds of civilians have been killed since a conflict erupted last month. The Western-led motion, which passed with 18 in favour and 15 against, had been…

Read More